The antifungal activity of normal and host-compromised saliva on spaceflight fungal phenotypes.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001203:Ascomycota / Q000254:growth & development*; D002470:Cell Survival; D003920:Diabetes Mellitus / Q000188:drug therapy; D005260:Female; D014644:Genetic Variation; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D007674:Kidney Diseases / Q000188:drug therapy; D008297:Male; D003904:Mitosporic Fungi / Q000254:growth & development*; D009369:Neoplasms / Q000532:radiotherapy; D010544:Peroxidases / Q000378:metabolism; D010641:Phenotype; D012441:Saccharomyces cerevisiae / Q000254:growth & development*; D012463:Saliva / Q000201:enzymology; D013026:Space Flight; D013172:Spores, Fungal / Q000254:growth & development; D014249:Trichophyton / Q000254:growth & development*
D000305:Adrenal Cortex Hormones; D007328:Insulin; D010544:Peroxidases